These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 8723789)

  • 21. Current good manufacturing practice and investigational new drugs intended for use in clinical trials. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2008 Jul; 73(136):40453-63. PubMed ID: 18850678
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Current good manufacturing practices for blood and blood components: notification of consignees receiving blood and blood components at increased risk for transmitting HIV infection--FDA. Final rule.
    Fed Regist; 1996 Sep; 61(175):47413-23. PubMed ID: 10160337
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ethical and legal aspects of placental/cord blood banking and transplant.
    Gluckman E;
    Hematol J; 2000; 1(1):67-9. PubMed ID: 11920171
    [No Abstract]   [Full Text] [Related]  

  • 24. Biological products: reporting of biological product deviations in manufacturing. Food and Drug Administration, HHS. Final rule.
    Fed Regist; 2000 Nov; 65(216):66621-35. PubMed ID: 11503696
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Revisions to labeling requirements for blood and blood components, including source plasma. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2012 Jan; 77(1):7-18. PubMed ID: 22242229
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Cord blood banking: public versus private banks--facts to ponder and consider].
    Dalle JH
    Arch Pediatr; 2005 Mar; 12(3):298-304. PubMed ID: 15734129
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Will regulation be the death of cell therapy in the United States?
    Gastineau DA
    Bone Marrow Transplant; 2004 Apr; 33(8):777-80. PubMed ID: 14968138
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cord blood banking.
    Birdsall M
    N Z Med J; 2005 Mar; 118(1211):U1361. PubMed ID: 15778759
    [No Abstract]   [Full Text] [Related]  

  • 29. The use of total quality principles to achieve regulatory compliance in research laboratories.
    Hynes MD
    Qual Assur; 1995 Mar; 4(1):34-40. PubMed ID: 8520863
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Establishment of an unrelated umbilical cord blood bank qualification program: ensuring quality while meeting Food and Drug Administration vendor qualification requirements.
    Rabe F; Kadidlo D; Van Orsow L; McKenna D
    Transfusion; 2013 Oct; 53(10):2243-7. PubMed ID: 23347170
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Saving the leftovers: models for banking cord blood stem cells.
    Cogdell KJ
    Issues Law Med; 2009; 25(2):145-65. PubMed ID: 20101907
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Quality control measures in cord blood banking in India - critical appraisal and recommendations.
    Vaidya A; Singhania S
    J Stem Cells; 2013; 8(2):105-13. PubMed ID: 24698987
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Exemption of certain transfusion services and clinical laboratories from registration: Food and Drug Administration. Final rule.
    Fed Regist; 1980 Dec; 45(251 Pt 1):85727-30. PubMed ID: 10298064
    [TBL] [Abstract][Full Text] [Related]  

  • 34. FDA's proposed regulatory approach to regulation of hematopoietic stem/progenitor cell products.
    Harvath L
    Cytotherapy; 1999; 1(4):358-9. PubMed ID: 20440912
    [No Abstract]   [Full Text] [Related]  

  • 35. Practical issues in tissue banking.
    Haimowitz MD
    Am J Clin Pathol; 1997 Apr; 107(4 Suppl 1):S75-81. PubMed ID: 9124234
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Safety aspects of cord blood banking.
    Warwick RM; Barbara JA
    Bone Marrow Transplant; 1998 Jun; 21 Suppl 3():S40-2. PubMed ID: 9712492
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The cord-blood-bank controversies.
    Steinbrook R
    N Engl J Med; 2004 Nov; 351(22):2255-7. PubMed ID: 15564539
    [No Abstract]   [Full Text] [Related]  

  • 38. The Milan Cord Blood Bank and the Italian Cord Blood Network.
    Lazzari L; Corsini C; Curioni C; Lecchi L; Scalamogna M; Rebulla P; Sirchia G
    J Hematother; 1996 Apr; 5(2):117-22. PubMed ID: 8723786
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cord blood unit access and selection: 2010 and beyond: best practices and emerging trends in cord blood unit selection.
    Boo M; Ballen K; Maiers M
    Biol Blood Marrow Transplant; 2011 Jan; 17(1 Suppl):S46-51. PubMed ID: 21195309
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cord blood beyond transplantation: can we use the experience to advance all cell therapies?
    Scaradavou A
    Br J Haematol; 2021 Jul; 194(1):14-27. PubMed ID: 33529385
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.